Clinical Trial Update: Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer

View source ↗

Summary

Clinical trial update noting that genetic polymorphisms may help predict chemotherapeutic outcomes in patients with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Breast Neoplasm, Drug Therapy | Status: COMPLETED